anistreplase vs placebo | No demonstrated result Bleeding by 196% (harmful effect) | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Deaths or MI | no data | In hospital death or MI | no data | In-hospital death | 2.96 [0.30 29.11] | p=1.00 | 0 | 159 | 1 | UNASEM, | myocardial infarction (fatal and non fatal) | 1.36 [0.69 2.68] | p=1.00 | 0 | 159 | 1 | UNASEM, | All cause death | no data | Bleeding | 2.96 [1.18 7.45] | p=0.04 | 0 | 159 | 1 | UNASEM, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |